ALK and non-small cell lung carcinoma: Taken together, the above-mentioned studies potentiate the role of TEPs as liquid biopsy biomarkers in ALK+ NSCLC; however, in order to implement this approach in the clinic, a few limitations still need to be overcome, such as standardization of TEPs detection and accessibility of this technique in hospitals.